1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ulcerative Colitis Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Ulcerative Colitis Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Drugs Stores
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Ulcerative Colitis Market Perspective (2017-2028)
2.2 Ulcerative Colitis Growth Trends by Region
2.2.1 Ulcerative Colitis Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Ulcerative Colitis Historic Market Size by Region (2017-2022)
2.2.3 Ulcerative Colitis Forecasted Market Size by Region (2023-2028)
2.3 Ulcerative Colitis Market Dynamics
2.3.1 Ulcerative Colitis Industry Trends
2.3.2 Ulcerative Colitis Market Drivers
2.3.3 Ulcerative Colitis Market Challenges
2.3.4 Ulcerative Colitis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ulcerative Colitis Players by Revenue
3.1.1 Global Top Ulcerative Colitis Players by Revenue (2017-2022)
3.1.2 Global Ulcerative Colitis Revenue Market Share by Players (2017-2022)
3.2 Global Ulcerative Colitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ulcerative Colitis Revenue
3.4 Global Ulcerative Colitis Market Concentration Ratio
3.4.1 Global Ulcerative Colitis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ulcerative Colitis Revenue in 2021
3.5 Ulcerative Colitis Key Players Head office and Area Served
3.6 Key Players Ulcerative Colitis Product Solution and Service
3.7 Date of Enter into Ulcerative Colitis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ulcerative Colitis Breakdown Data by Type
4.1 Global Ulcerative Colitis Historic Market Size by Type (2017-2022)
4.2 Global Ulcerative Colitis Forecasted Market Size by Type (2023-2028)
5 Ulcerative Colitis Breakdown Data by Application
5.1 Global Ulcerative Colitis Historic Market Size by Application (2017-2022)
5.2 Global Ulcerative Colitis Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Ulcerative Colitis Market Size (2017-2028)
6.2 North America Ulcerative Colitis Market Size by Country (2017-2022)
6.3 North America Ulcerative Colitis Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Ulcerative Colitis Market Size (2017-2028)
7.2 Europe Ulcerative Colitis Market Size by Country (2017-2022)
7.3 Europe Ulcerative Colitis Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ulcerative Colitis Market Size (2017-2028)
8.2 Asia-Pacific Ulcerative Colitis Market Size by Country (2017-2022)
8.3 Asia-Pacific Ulcerative Colitis Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Ulcerative Colitis Market Size (2017-2028)
9.2 Latin America Ulcerative Colitis Market Size by Country (2017-2022)
9.3 Latin America Ulcerative Colitis Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ulcerative Colitis Market Size (2017-2028)
10.2 Middle East & Africa Ulcerative Colitis Market Size by Country (2017-2022)
10.3 Middle East & Africa Ulcerative Colitis Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Johnson & Johnson.
11.1.1 Johnson & Johnson. Company Detail
11.1.2 Johnson & Johnson. Business Overview
11.1.3 Johnson & Johnson. Ulcerative Colitis Introduction
11.1.4 Johnson & Johnson. Revenue in Ulcerative Colitis Business (2017-2022)
11.1.5 Johnson & Johnson. Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Detail
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Ulcerative Colitis Introduction
11.2.4 AbbVie Revenue in Ulcerative Colitis Business (2017-2022)
11.2.5 AbbVie Recent Development
11.3 Takeda Pharmaceuticals
11.3.1 Takeda Pharmaceuticals Company Detail
11.3.2 Takeda Pharmaceuticals Business Overview
11.3.3 Takeda Pharmaceuticals Ulcerative Colitis Introduction
11.3.4 Takeda Pharmaceuticals Revenue in Ulcerative Colitis Business (2017-2022)
11.3.5 Takeda Pharmaceuticals Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Ulcerative Colitis Introduction
11.4.4 Roche Revenue in Ulcerative Colitis Business (2017-2022)
11.4.5 Roche Recent Development
11.5 Warner Chilcott
11.5.1 Warner Chilcott Company Detail
11.5.2 Warner Chilcott Business Overview
11.5.3 Warner Chilcott Ulcerative Colitis Introduction
11.5.4 Warner Chilcott Revenue in Ulcerative Colitis Business (2017-2022)
11.5.5 Warner Chilcott Recent Development
11.6 Salix Pharmaceuticals/Santarus
11.6.1 Salix Pharmaceuticals/Santarus Company Detail
11.6.2 Salix Pharmaceuticals/Santarus Business Overview
11.6.3 Salix Pharmaceuticals/Santarus Ulcerative Colitis Introduction
11.6.4 Salix Pharmaceuticals/Santarus Revenue in Ulcerative Colitis Business (2017-2022)
11.6.5 Salix Pharmaceuticals/Santarus Recent Development
11.7 Takeda
11.7.1 Takeda Company Detail
11.7.2 Takeda Business Overview
11.7.3 Takeda Ulcerative Colitis Introduction
11.7.4 Takeda Revenue in Ulcerative Colitis Business (2017-2022)
11.7.5 Takeda Recent Development
11.8 Ferring Pharmaceuticals
11.8.1 Ferring Pharmaceuticals Company Detail
11.8.2 Ferring Pharmaceuticals Business Overview
11.8.3 Ferring Pharmaceuticals Ulcerative Colitis Introduction
11.8.4 Ferring Pharmaceuticals Revenue in Ulcerative Colitis Business (2017-2022)
11.8.5 Ferring Pharmaceuticals Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Ulcerative Colitis Introduction
11.9.4 Pfizer Revenue in Ulcerative Colitis Business (2017-2022)
11.9.5 Pfizer Recent Development
11.10 InDeX Pharmaceuticals
11.10.1 InDeX Pharmaceuticals Company Detail
11.10.2 InDeX Pharmaceuticals Business Overview
11.10.3 InDeX Pharmaceuticals Ulcerative Colitis Introduction
11.10.4 InDeX Pharmaceuticals Revenue in Ulcerative Colitis Business (2017-2022)
11.10.5 InDeX Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Ulcerative Colitis Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Ulcerative Colitis Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Ulcerative Colitis Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Ulcerative Colitis Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Ulcerative Colitis Market Share by Region (2017-2022)
Table 8. Global Ulcerative Colitis Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Ulcerative Colitis Market Share by Region (2023-2028)
Table 10. Ulcerative Colitis Market Trends
Table 11. Ulcerative Colitis Market Drivers
Table 12. Ulcerative Colitis Market Challenges
Table 13. Ulcerative Colitis Market Restraints
Table 14. Global Ulcerative Colitis Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Ulcerative Colitis Market Share by Players (2017-2022)
Table 16. Global Top Ulcerative Colitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ulcerative Colitis as of 2021)
Table 17. Ranking of Global Top Ulcerative Colitis Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Ulcerative Colitis Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Ulcerative Colitis Product Solution and Service
Table 21. Date of Enter into Ulcerative Colitis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Ulcerative Colitis Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Ulcerative Colitis Revenue Market Share by Type (2017-2022)
Table 25. Global Ulcerative Colitis Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Ulcerative Colitis Revenue Market Share by Type (2023-2028)
Table 27. Global Ulcerative Colitis Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Ulcerative Colitis Revenue Market Share by Application (2017-2022)
Table 29. Global Ulcerative Colitis Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Ulcerative Colitis Revenue Market Share by Application (2023-2028)
Table 31. North America Ulcerative Colitis Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Ulcerative Colitis Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Ulcerative Colitis Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Ulcerative Colitis Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Ulcerative Colitis Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Ulcerative Colitis Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Ulcerative Colitis Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Ulcerative Colitis Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Ulcerative Colitis Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Ulcerative Colitis Market Size by Country (2023-2028) & (US$ Million)
Table 41. Johnson & Johnson. Company Detail
Table 42. Johnson & Johnson. Business Overview
Table 43. Johnson & Johnson. Ulcerative Colitis Product
Table 44. Johnson & Johnson. Revenue in Ulcerative Colitis Business (2017-2022) & (US$ Million)
Table 45. Johnson & Johnson. Recent Development
Table 46. AbbVie Company Detail
Table 47. AbbVie Business Overview
Table 48. AbbVie Ulcerative Colitis Product
Table 49. AbbVie Revenue in Ulcerative Colitis Business (2017-2022) & (US$ Million)
Table 50. AbbVie Recent Development
Table 51. Takeda Pharmaceuticals Company Detail
Table 52. Takeda Pharmaceuticals Business Overview
Table 53. Takeda Pharmaceuticals Ulcerative Colitis Product
Table 54. Takeda Pharmaceuticals Revenue in Ulcerative Colitis Business (2017-2022) & (US$ Million)
Table 55. Takeda Pharmaceuticals Recent Development
Table 56. Roche Company Detail
Table 57. Roche Business Overview
Table 58. Roche Ulcerative Colitis Product
Table 59. Roche Revenue in Ulcerative Colitis Business (2017-2022) & (US$ Million)
Table 60. Roche Recent Development
Table 61. Warner Chilcott Company Detail
Table 62. Warner Chilcott Business Overview
Table 63. Warner Chilcott Ulcerative Colitis Product
Table 64. Warner Chilcott Revenue in Ulcerative Colitis Business (2017-2022) & (US$ Million)
Table 65. Warner Chilcott Recent Development
Table 66. Salix Pharmaceuticals/Santarus Company Detail
Table 67. Salix Pharmaceuticals/Santarus Business Overview
Table 68. Salix Pharmaceuticals/Santarus Ulcerative Colitis Product
Table 69. Salix Pharmaceuticals/Santarus Revenue in Ulcerative Colitis Business (2017-2022) & (US$ Million)
Table 70. Salix Pharmaceuticals/Santarus Recent Development
Table 71. Takeda Company Detail
Table 72. Takeda Business Overview
Table 73. Takeda Ulcerative Colitis Product
Table 74. Takeda Revenue in Ulcerative Colitis Business (2017-2022) & (US$ Million)
Table 75. Takeda Recent Development
Table 76. Ferring Pharmaceuticals Company Detail
Table 77. Ferring Pharmaceuticals Business Overview
Table 78. Ferring Pharmaceuticals Ulcerative Colitis Product
Table 79. Ferring Pharmaceuticals Revenue in Ulcerative Colitis Business (2017-2022) & (US$ Million)
Table 80. Ferring Pharmaceuticals Recent Development
Table 81. Pfizer Company Detail
Table 82. Pfizer Business Overview
Table 83. Pfizer Ulcerative Colitis Product
Table 84. Pfizer Revenue in Ulcerative Colitis Business (2017-2022) & (US$ Million)
Table 85. Pfizer Recent Development
Table 86. InDeX Pharmaceuticals Company Detail
Table 87. InDeX Pharmaceuticals Business Overview
Table 88. InDeX Pharmaceuticals Ulcerative Colitis Product
Table 89. InDeX Pharmaceuticals Revenue in Ulcerative Colitis Business (2017-2022) & (US$ Million)
Table 90. InDeX Pharmaceuticals Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ulcerative Colitis Market Share by Type: 2021 VS 2028
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Global Ulcerative Colitis Market Share by Application in 2021 & 2028
Figure 5. Hospital Case Studies
Figure 6. Drugs Stores Case Studies
Figure 7. Ulcerative Colitis Report Years Considered
Figure 8. Global Ulcerative Colitis Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Ulcerative Colitis Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Ulcerative Colitis Market Share by Region: 2021 VS 2028
Figure 11. Global Ulcerative Colitis Market Share by Players in 2021
Figure 12. Global Top Ulcerative Colitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ulcerative Colitis as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Ulcerative Colitis Revenue in 2021
Figure 14. North America Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 15. North America Ulcerative Colitis Market Share by Country (2017-2028)
Figure 16. United States Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. Canada Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Europe Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Ulcerative Colitis Market Share by Country (2017-2028)
Figure 20. Germany Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. France Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. U.K. Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Italy Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Russia Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Nordic Countries Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Ulcerative Colitis Market Share by Region (2017-2028)
Figure 28. China Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Japan Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. South Korea Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Southeast Asia Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. India Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Australia Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Latin America Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Ulcerative Colitis Market Share by Country (2017-2028)
Figure 36. Mexico Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Brazil Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Middle East & Africa Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Ulcerative Colitis Market Share by Country (2017-2028)
Figure 40. Turkey Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Saudi Arabia Ulcerative Colitis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Johnson & Johnson. Revenue Growth Rate in Ulcerative Colitis Business (2017-2022)
Figure 43. AbbVie Revenue Growth Rate in Ulcerative Colitis Business (2017-2022)
Figure 44. Takeda Pharmaceuticals Revenue Growth Rate in Ulcerative Colitis Business (2017-2022)
Figure 45. Roche Revenue Growth Rate in Ulcerative Colitis Business (2017-2022)
Figure 46. Warner Chilcott Revenue Growth Rate in Ulcerative Colitis Business (2017-2022)
Figure 47. Salix Pharmaceuticals/Santarus Revenue Growth Rate in Ulcerative Colitis Business (2017-2022)
Figure 48. Takeda Revenue Growth Rate in Ulcerative Colitis Business (2017-2022)
Figure 49. Ferring Pharmaceuticals Revenue Growth Rate in Ulcerative Colitis Business (2017-2022)
Figure 50. Pfizer Revenue Growth Rate in Ulcerative Colitis Business (2017-2022)
Figure 51. InDeX Pharmaceuticals Revenue Growth Rate in Ulcerative Colitis Business (2017-2022)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Johnson & Johnson. AbbVie Takeda Pharmaceuticals Roche Warner Chilcott Salix Pharmaceuticals/Santarus Takeda Ferring Pharmaceuticals Pfizer InDeX Pharmaceuticals